Company: INKT
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-061041
Chunk: 41

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 41
---
 including a termination due to voluntary resignation, retirement, involuntary termination, layoff, death or disability, would retain his or her Eligible Options subject to their existing terms and will not be eligible to receive new stock options in the Option Exchange.

Eligible Options

As of April 24, 2025, Eligible Holders held outstanding options to purchase 867,341 shares of common stock with a weighted average exercise price of $17.78 per share, of which 77% were underwater, meaning the exercise price of the option exceeded $7.50 (the closing price of a share of our common stock on April 24, 2025). Of the stock options held by Eligible Holders, outstanding options to purchase 667,059 shares of common stock had an exercise price equal to or greater than $8.50 per share and otherwise met the criteria to be considered Eligible Options for purposes of the Option Exchange. The weighted-average exercise price and weighted average remaining life of the Eligible Options is $22.97 and 1.1 years, respectively. No Eligible Options were issued after January 16, 2024 and all Eligible Options were issued at least 15 months prior to April 24, 2025.

The following chart illustrates the breakdown of Eligible Options by their exercise price, as of April 24, 2025.

<div align='center'>28</div>

The following chart illustrates the breakdown of Eligible Options by the year in which they were granted, as of April 24, 2025.

<div align='center'>29</div>

The following table sets forth the number of Eligible Options held by our named executive officers, our other executive officers as a group, our non-executive directors, our other employees as a group, and our other consultants as a group. No employees, other than Dr. Buell, hold more than 5% of the total Eligible Options.

| Eligible Stock Options              |     |                           |         |     |                         |         |     |       |         |
| Name                                |     | Unvested Eligible Options |         |     | Vested Eligible Options |         |     | Total |         |
| Jennifer S. Buell, Ph.D.            |     |                           | 154,036 |     |                         | 203,660 |     |       | 357,696 |
| Marc van Dijk, Ph.D.                |     |                           |  11,561